Eli Lilly and Novo Nordisk dominate the weight-loss market. Yet Pfizer, Roche and others are scooping up new drugs in a bid ...
Obesity treatment is hurtling into a new era: once-a-week GLP-1 injections are edging toward the dramatic results of ...
Jane McClenaghan on the worrying picture of Northern Ireland’s eating habits, as new survey reveals alarmingly low fruit and ...
On September 26, Danish pharma multinational Novo Nordisk got the Indian drug regulator Central Drugs Standard Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback